bluebird bio, Inc. - COM (BLUE)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
78.3M
Holdings value Q2 2024
$77M
Value change Q2 2024
-$30.1M
Grand Portfolio weight change Q2 2024
0%
Number of holders
147
Number of buys Q2 2024
57
Number of sells Q2 2024
-76
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 136K $70.6K +$38.6K $0.52 3
2024 Q2 78.3M $77M -$30.1M $0.98 148
2024 Q1 103M $131M -$37.7M $1.28 154
2023 Q4 130M $180M +$45.8M $1.38 184
2023 Q3 89.4M $272M -$13M $3.04 161
2023 Q2 93.5M $308M -$10.1M $3.29 169
2023 Q1 97.2M $309M +$83.3M $3.18 172
2022 Q4 67.9M $470M +$18.8M $6.92 176
2022 Q3 65.5M $415M +$75.4M $6.33 150
2022 Q2 55M $228M -$28.7M $4.14 135
2022 Q1 61.9M $300M -$32M $4.85 158
2021 Q4 58.1M $580M +$42.5M $9.99 149
2021 Q3 51.5M $983M -$81.6M $19.11 173
2021 Q2 53M $1.69B +$43M $31.98 222
2021 Q1 51.7M $1.56B -$565M $30.15 210
2020 Q4 62.1M $2.69B -$65.7M $43.27 251
2020 Q3 64.3M $3.47B -$84.3M $53.95 270
2020 Q2 64.4M $3.93B +$368M $61.04 273
2020 Q1 58.2M $2.68B -$113M $45.96 232
2019 Q4 60.1M $5.27B -$360M $87.75 269
2019 Q3 63.9M $5.86B +$156M $91.82 237
2019 Q2 62.2M $7.91B +$130M $127.20 274
2019 Q1 62.3M $9.8B +$244M $157.33 287
2018 Q4 61M $6.06B +$247M $99.20 242
2018 Q3 58M $8.47B +$650M $146.00 288
2018 Q2 53.5M $8.4B +$118M $156.95 305
2018 Q1 52.7M $9B +$95M $170.75 303
2017 Q4 52.1M $9.28B +$314M $178.10 300
2017 Q3 50.2M $6.9B +$151M $137.35 239
2017 Q2 49.2M $5.16B +$298M $105.05 237
2017 Q1 46.6M $4.24B +$267M $90.90 207
2016 Q4 46.6M $2.88B +$110M $61.70 197
2016 Q3 44.6M $3.02B +$120M $67.78 198
2016 Q2 43.7M $1.89B +$143M $43.29 174
2016 Q1 40.3M $1.71B +$9.54M $42.50 180
2015 Q4 39.4M $2.53B +$112M $64.22 191
2015 Q3 36.2M $3.09B +$54M $85.55 188
2015 Q2 34.6M $5.83B +$607M $168.37 234
2015 Q1 31.5M $3.81B +$245M $120.77 211
2014 Q4 29.9M $2.74B +$554M $91.72 172
2014 Q3 23.5M $843M +$150M $35.88 119
2014 Q2 19.2M $742M +$59.8M $38.57 103
2014 Q1 18.1M $411M +$13.2M $22.74 79